# Keragon

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/keragon

- Industry: Software
- Headquarters: Boston, US
- Website: www.keragon.com
- Total disclosed funding: $7.5M
- Latest round: Seed (Feb 12, 2025)
- Investors on record: 4

## About

Based in Massachusetts, US, and founded in 2022, Keragon Inc operates as a developer of an artificial intelligence (AI)based solution for the healthcare sector. In February 2025, Keragon Inc raised EUR 7.2 million in seed funding led by new investor Upfront Ventures, with participation from returning investors Afore Capital, Focal and 25madison Ventures. The firm, as of June 2024, is led by its CEO, Conno Christou, and CTO, Panos Papageorgiou. The company through its AI-powered automation platform, Keragon, expedites healthcare product development while ensuring compliance with the Health Insurance Portability and Accountability Act (HIPAA). Keragon is a no-code platform designed to integrate various healthcare software systems. Users can automate workflows such as patient intake, triage, messaging, diagnostics ordering, care plan delivery, appointment scheduling, and data synchronization. With over 100 pre-built integrations, Keragon connects to popular tools like Zoom, Typeform, Twilio, Salesforce Health Cloud, and many more, allowing healthcare providers to enhance operational efficiency without extensive engineering resources. The company will use the February 2025 funding to support its expansion and development.

## Funding rounds

- Seed, Feb 12, 2025, $7.5M — Upfront, Afore Capital, 25Madison Ventures, Focal

## Investors

- Upfront (https://capitalatlas.ai/funds/upfront) — Seed
- Afore Capital (https://capitalatlas.ai/funds/afore-capital) — Seed
- 25Madison Ventures (https://capitalatlas.ai/funds/25madison-ventures) — Seed
- Focal (https://capitalatlas.ai/funds/focal) — Seed